Loading clinical trials...
Loading clinical trials...
Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin: a Multicenter, Prospective, Observational Study in a Real World Setting
Conditions
Interventions
Brentuximab Vedotin
Locations
9
Russia
Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Chelyabinsk, Russia
Republican Clinical Oncology Center of the Ministry of Health of the Republic of Tatarstan
Kazan', Russia
N.I. Pirogov National Medical Surgical Center
Moscow, Russia
Clinical Onclological Center
Omsk, Russia
Almazov National Medical Research Centre
Saint Petersburg, Russia
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Saint Petersburg, Russia
Start Date
April 2, 2018
Primary Completion Date
May 1, 2020
Completion Date
May 1, 2020
Last Updated
October 28, 2019
Lead Sponsor
Multinational Center for Quality of Life Research, Russia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions